Krautbauer Sabrina, Neumeier Markus, Rein-Fischboeck Lisa, Haberl Elisabeth M, Tilg Herbert, Eisinger Kristina, Buechler Christa
Department of Internal Medicine I, Regensburg University Hospital, Regensburg, Germany.
Department of Internal Medicine I, Gastroenterology, Hepatology, Metabolism & Endocrinology, Medical University Innsbruck, Innsbruck, Austria.
Cell Physiol Biochem. 2019;52(5):1151-1165. doi: 10.33594/000000078.
BACKGROUND/AIMS: Adipocyte hypertrophy in obesity is associated with inflammation and adipose tissue fibrosis which both contribute to metabolic diseases. Mechanisms regulating lipid droplet expansion are poorly understood. Knock down of the scaffold protein beta 2 syntrophin (SNTB2) increases lipid droplet size of 3T3-L1 adipocytes and the physiological relevance of SNTB2 in adipose tissue morphology and metabolic health was analyzed herein.
Wild type and SNTB2 mice were challenged with 24 weeks high fat diet. Adipose tissue morphology and expression of various genes / proteins including collagens and caveolin-1 was examined. Glucose, insulin, fasting and fed free fatty acids were measured in serum. SNTB2 expression was determined in adipose tissues of patients.
Upon high fat diet SNTB2 mice displayed reduced adiposity and adipocyte hypertrophy. Expression of various proteins was normal in the different white fat depots of SNTB2 mice while caveolin-1 protein and collagen mRNA levels were diminished. Null mice had reduced systemic glucose while fasting and postprandial insulin and insulin response were normal. Fatty acid clearance in the fed state and after insulin injection was enhanced. SNTB2 and caveolin-1 were increased in fat of ob/ob mice. However, no correlation between body mass index and SNTB2 protein in adipose tissues of seven patients was found. In subcutaneous but not in visceral fat the ratio of SNTB2 to alpha syntrophin protein, which affects lipid droplet size in the opposite manner, was associated with BMI. In subcutaneous fat of extremely obese patients SNTB2 mRNA levels were not correlated with weight loss after bariatric surgery.
Current study shows that high SNTB2 in obese adipose tissues restricts adipocyte growth and thereby may contribute to metabolic diseases.
背景/目的:肥胖症中的脂肪细胞肥大与炎症和脂肪组织纤维化相关,这两者都会导致代谢性疾病。调节脂滴扩张的机制尚不清楚。支架蛋白β2肌养蛋白(SNTB2)的敲低会增加3T3-L1脂肪细胞的脂滴大小,本文分析了SNTB2在脂肪组织形态和代谢健康中的生理相关性。
野生型和SNTB2基因敲除小鼠接受24周的高脂饮食。检测脂肪组织形态以及包括胶原蛋白和小窝蛋白-1在内的各种基因/蛋白质的表达。测量血清中的葡萄糖、胰岛素、空腹和餐后游离脂肪酸。测定患者脂肪组织中的SNTB2表达。
高脂饮食后,SNTB2基因敲除小鼠的肥胖和脂肪细胞肥大减少。SNTB2基因敲除小鼠不同白色脂肪库中各种蛋白质的表达正常,而小窝蛋白-1蛋白和胶原蛋白mRNA水平降低。基因敲除小鼠在空腹时的全身葡萄糖水平降低,餐后胰岛素和胰岛素反应正常。进食状态下和注射胰岛素后的脂肪酸清除增强。ob/ob小鼠脂肪中的SNTB2和小窝蛋白-1增加。然而,在7名患者的脂肪组织中未发现体重指数与SNTB2蛋白之间存在相关性。在皮下脂肪而非内脏脂肪中,以相反方式影响脂滴大小的SNTB2与α肌养蛋白的蛋白比例与BMI相关。在极度肥胖患者的皮下脂肪中,SNTB2 mRNA水平与减肥手术后的体重减轻无关。
当前研究表明,肥胖脂肪组织中高表达的SNTB2会限制脂肪细胞生长,从而可能导致代谢性疾病。